Patent · US Active

Modulation of insulin like growth factor I receptor expression in cancer

US9084770B2 · kind B2 · utility

2Cited by

0References

21Claims

0Family size

Assignee

Antisense Therapeutics Ltd · AU

Inventors

George Tachas · Melbourne, AU
Lynne Maree Atley · Williamstown, AU
Christopher John Wraight · Melbourne, AU

Key dates

Filing date	Oct 13, 2009
Grant date	Jul 21, 2015
Priority date	—
Expiry date	Jul 4, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods, compounds, and compositions for reducing expression of an IGF-IR mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions that inhibit expression of IGF-IR in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate the tumor or cancer, or a symptom thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.